Cantitate/Preț
Produs

Substance Use Disorders: From Etiology to Treatment: Handbook of Experimental Pharmacology, cartea 258

Editat de Michael A. Nader, Yasmin L. Hurd
en Limba Engleză Paperback – 20 mai 2021
The purpose of this book is to provide a broad scope of substance use disorder research and how these findings can impact treatment outcomes. The research and outcomes described in this book represent important principles related to identifying and understanding factors related to substance use disorders. The first section is dedicated to methodology including population-based surveys, basic neuroanatomy, chemistry, molecular biology, behavioral models and brain imaging. The second section utilizes this methodology in research related to opioids, cocaine, marijuana, alcohol and nicotine. The book is aimed at both professionals (academics, clinicians, practitioners) and students or trainees.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 108372 lei  6-8 săpt.
  Springer International Publishing – 20 mai 2021 108372 lei  6-8 săpt.
Hardback (1) 109091 lei  6-8 săpt.
  Springer International Publishing – 20 mai 2020 109091 lei  6-8 săpt.

Din seria Handbook of Experimental Pharmacology

Preț: 108372 lei

Preț vechi: 114075 lei
-5% Nou

Puncte Express: 1626

Preț estimativ în valută:
20740 21544$ 17228£

Carte tipărită la comandă

Livrare economică 03-17 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030336813
ISBN-10: 3030336816
Ilustrații: X, 502 p. 1 illus.
Dimensiuni: 155 x 235 mm
Greutate: 0.71 kg
Ediția:1st ed. 2020
Editura: Springer International Publishing
Colecția Springer
Seria Handbook of Experimental Pharmacology

Locul publicării:Cham, Switzerland

Cuprins

1. Methods for Population Research on Substance Use and Consequences.- 2. Translational Molecular Approaches  in Substance Abuse Research.- 3. Small Molecule Neuropeptide-S and Melanocortin  Receptor Ligands  As Potential Treatments for Substance Use Disorders.- 4. Emerging Insights into Mu Opioid Pharmacology.- 5. Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors.- 6. The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research.- 7. Clinical Trials for Opioid Use Disorder.- 8. Modelling Differential Vulnerability  to Substance Use Disorder in Rodents:  Neurobiological Mechanisms.- 9. Activity-Dependent Epigenetic Remodeling  in Cocaine Use Disorder.- 10. Molecular Mechanisms of Amphetamines.- 11. Clinical Trials for Stimulant Use Disorders:  Addressing Heterogeneities That May  Undermine Treatment Outcomes.- 12. Molecular Mechanism and Cannabinoid  Pharmacology.- 13. Pharmacotherapies for Cannabis Use Disorders:Clinical Challenges and Promising Therapeutic Agents.- 14. Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence.- 15. Randomized Clinical Trials Investigating Innovative Interventions for Smoking Cessation in the Last Decade.- 16. Adolescent Vulnerability to Alcohol Use  Disorder: Neurophysiological Mechanisms  from Preclinical Studies.- 17. Medication Development for Alcohol Use  Disorder: A Focus on Clinical Studies.- 18. Newly Emerging Drugs of Abuse.



Caracteristici

Focuses on each substance used and abused from epidemiology, molecular biology, animal models and human subjects/clinical research reinforcing basic principles of pharmacology throughout Broadens understanding of the commonalities and differences associated with each drug of abuse Provides the reader with state-of-the-art, cutting edge research methods